Daxor Corp (DXR)
$9.5
Insights on Daxor Corp
Increasing Revenue
Revenue is up for the last 3 quarters, -1.76M → 36.35M (in $), with an average increase of 2235.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -3.03M → 3.31M (in $), with an average increase of 166.5% per quarter
Vs ISRG
In the last 1 year, Intuitive Surgical, Inc. has given 28.2% return, outperforming this stock by 26.4%
Vs ISRG
In the last 3 years, Intuitive Surgical, Inc. has given 46.2% return, outperforming this stock by 46.9%
Performance
- $9.35$9.50$9.50
1.58%
Downside
Day's Volatility :1.58%
Upside
0.0%
- $7.11$10.15$9.50
25.16%
Downside
52 Weeks Volatility :29.95%
Upside
6.4%
Returns
| Period | Daxor Corp | Index (Russel 2000) |
|---|---|---|
3 Months | 17.33% | 0.0% |
6 Months | 21.91% | 0.0% |
1 Year | 1.79% | 0.0% |
3 Years | 0.83% | -20.1% |
Highlights
Market Capitalization | 46.5M |
Book Value | $7.08 |
Earnings Per Share (EPS) | 0.14 |
PE Ratio | 69.18 |
PEG Ratio | 0.0 |
Wall Street Target Price | 23.25 |
Profit Margin | 171.73% |
Operating Margin TTM | -511.34% |
Return On Assets TTM | -1.51% |
Return On Equity TTM | 0.89% |
Revenue TTM | 163.4K |
Revenue Per Share TTM | 0.03 |
Quarterly Revenue Growth YOY | -14.499999999999998% |
Gross Profit TTM | 231.6K |
Diluted Eps TTM | 0.14 |
Quarterly Earnings Growth YOY | -0.58 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 144.74%
Technicals Summary
Sell
Neutral
Buy
Daxor Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Daxor Corp | -1.12% | 21.91% | 1.79% | 0.83% | 19.65% |
 Intuitive Surgical, Inc. | 8.99% | 27.33% | 28.22% | 44.48% | 148.54% |
 Resmed Inc. | 21.03% | 43.03% | -3.18% | 5.79% | 92.96% |
 Becton, Dickinson And Company | 0.42% | -0.82% | -6.45% | -3.64% | -0.35% |
 West Pharmaceutical Services Inc | -10.21% | -4.03% | -3.96% | -0.74% | 185.12% |
 Alcon Ag | 10.04% | 21.77% | 8.54% | 28.89% | 50.75% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Daxor Corp | 69.18 | 69.18 | 0.0 | 0.0 | 0.01 | -0.02 | NA | 7.08 |
Intuitive Surgical, Inc. | 72.47 | 72.47 | 7.13 | 6.28 | 0.16 | 0.08 | NA | 39.37 |
Resmed Inc. | 33.68 | 33.68 | 1.75 | 7.73 | 0.22 | 0.12 | 0.01 | 31.52 |
Becton, Dickinson And Company | 50.78 | 50.78 | 1.34 | 13.04 | 0.05 | 0.03 | 0.02 | 88.74 |
West Pharmaceutical Services Inc | 45.28 | 45.28 | 6.72 | 7.76 | 0.21 | 0.11 | 0.0 | 36.72 |
Alcon Ag | 41.75 | 41.75 | 4.59 | 3.07 | 0.05 | 0.02 | 0.0 | 42.13 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Daxor Corp | Buy | $46.5M | 19.65% | 69.18 | 171.73% |
Intuitive Surgical, Inc. | Buy | $141.9B | 148.54% | 72.47 | 27.16% |
Resmed Inc. | Buy | $32.1B | 92.96% | 33.68 | 20.91% |
Becton, Dickinson And Company | Buy | $68.5B | -0.35% | 50.78 | 6.76% |
West Pharmaceutical Services Inc | Buy | $25.1B | 185.12% | 45.28 | 19.42% |
Alcon Ag | Buy | $43.5B | 50.75% | 41.75 | 10.96% |
Institutional Holdings
Vanguard Group Inc
0.98%Renaissance Technologies Corp
0.32%Keyes Stange & Wooten Wealth Management LLC
0.23%Princeton Global Asset Management LLC
0.01%
Company Information
the bva-100 (blood volume analyzer) is the first instrument of its kind that can precisely measure the amount of blood a patient has in their body. blood volume measurements have been available for almost 60 years, but the test often took 4 to 8 hours to perform and was very difficult to perform accurately. due to these issues, blood volume measurements were very rarely done. physicians had been forced to rely on substitute tests that were only able to measure the thickness of the blood and can be very misleading in many surgical and medical situations. the bva-100 can measure blood volume: accurately, quickly & reliably.
Organization | Daxor Corp |
Employees | 0 |
CEO | Mr. Michael Richard Feldschuh |
Industry | Health Technology |
Discover More
A Spac I Acquisition Corp
$9.50
-1.86%
Keyarch Acquisition Corp
$9.50
-1.86%
Connexa Sports Technologies Inc
$9.50
-1.86%
Us Value Etf
$9.50
-1.86%
First Wave Biopharma Inc
$9.50
-1.86%
Global X Msci Next Emerging
$9.50
-1.86%
Fat Projects Acquisition Corp
$9.50
-1.86%
Ishares Intl Div Growth Etf
$9.50
-1.86%
Corsair Gaming, Inc.
$9.50
-1.86%